Roche Holding AG (XSWX:ROP)
CHF 332 +6.8 (+2.09%) Market Cap: 264.93 Bil Enterprise Value: 286.73 Bil PE Ratio: 20.28 PB Ratio: 7.66 GF Score: 79/100

Full Year 2023 Roche Holding AG Earnings Presentation Transcript

Feb 01, 2024 / 01:00PM GMT
Release Date Price: CHF233.5 (-5.50%)

Feb 01, 2024 / 01:00PM GMT
Presentation
Feb 01, 2024 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Bruno Eschli
Roche Holding AG - Head of IR
* Matthew Sause
Roche Diagnostics Corporation - CEO
* Teresa A. Graham
Roche Holding AG - CEO of Roche Pharmaceuticals
* Thomas Schinecker
Roche Holding AG - CEO

=====================
Conference Call Participants
=====================
* Charles David Mabbutt
Morgan Stanley, Research Division - Research Associate
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - European Head of Biopharma
* John Priestner
JPMorgan Chase & Co, Research Division - Research Analyst
* Matthew Weston
UBS Investment Bank, Research Division - Analyst
* Richard J. Parkes
BNP Paribas Exane, Research Division - Head of Pharmaceutical and Biotechnology & Analyst
* Richard Wagner
* Sachin Jain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot